Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
NCT04507763
·
clinicaltrials.gov ↗
COMPLETED
Status
763
Enrollment
INDUSTRY
Sponsor class
Conditions
Ankylosing Spondylitis
Interventions
DRUG:
Etanercept
Sponsor
Pfizer